MDGL logo

Madrigal Pharmaceuticals (MDGL) Net Income

Annual Net Income

-$373.63 M
-$78.28 M-26.50%

December 31, 2023


Summary


Performance

MDGL Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMDGLprofitabilitymetrics:

Quarterly Net Income

-$106.96 M
+$45.01 M+29.62%

September 30, 2024


Summary


Performance

MDGL Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMDGLprofitabilitymetrics:

TTM Net Income

-$518.67 M
-$8.22 M-1.61%

September 30, 2024


Summary


Performance

MDGL TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMDGLprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

MDGL Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-26.5%+29.6%-1.6%
3 y3 years-84.7%+29.6%-1.6%
5 y5 years-1038.7%+29.6%-1.6%

MDGL Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-54.5%at low-86.0%+29.6%-114.5%at low
5 y5-year-345.1%at low-285.6%+29.6%-517.9%at low
alltimeall time-572.4%at low-190.6%+29.6%-656.0%at low

Madrigal Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$106.96 M(-29.6%)
-$518.67 M(+1.6%)
Jun 2024
-
-$151.97 M(+3.0%)
-$510.45 M(+14.9%)
Mar 2024
-
-$147.54 M(+31.5%)
-$444.27 M(+18.9%)
Dec 2023
-$373.63 M(+26.5%)
-$112.19 M(+13.6%)
-$373.63 M(+7.6%)
Sep 2023
-
-$98.74 M(+15.1%)
-$347.34 M(+5.3%)
Jun 2023
-
-$85.80 M(+11.6%)
-$329.80 M(+4.8%)
Mar 2023
-
-$76.90 M(-10.5%)
-$314.73 M(+6.6%)
Dec 2022
-$295.35 M(+22.1%)
-$85.91 M(+5.8%)
-$295.35 M(+7.8%)
Sep 2022
-
-$81.20 M(+14.8%)
-$273.99 M(+7.1%)
Jun 2022
-
-$70.73 M(+23.0%)
-$255.90 M(+3.7%)
Mar 2022
-
-$57.52 M(-10.9%)
-$246.82 M(+2.1%)
Dec 2021
-$241.85 M(+19.6%)
-$64.55 M(+2.3%)
-$241.85 M(+2.3%)
Sep 2021
-
-$63.10 M(+2.4%)
-$236.42 M(+2.2%)
Jun 2021
-
-$61.65 M(+17.3%)
-$231.28 M(+5.8%)
Mar 2021
-
-$52.55 M(-11.1%)
-$218.66 M(+8.1%)
Dec 2020
-$202.24 M(+140.9%)
-$59.12 M(+2.0%)
-$202.24 M(+18.4%)
Sep 2020
-
-$57.96 M(+18.2%)
-$170.86 M(+27.2%)
Jun 2020
-
-$49.02 M(+35.7%)
-$134.33 M(+27.9%)
Mar 2020
-
-$36.13 M(+30.3%)
-$105.00 M(+25.1%)
Dec 2019
-$83.95 M(+155.9%)
-$27.74 M(+29.5%)
-$83.95 M(+24.0%)
Sep 2019
-
-$21.43 M(+8.8%)
-$67.68 M(+23.6%)
Jun 2019
-
-$19.70 M(+30.6%)
-$54.77 M(+31.9%)
Mar 2019
-
-$15.08 M(+31.4%)
-$41.53 M(+26.6%)
Dec 2018
-$32.81 M(+5.3%)
-$11.47 M(+34.8%)
-$32.81 M(+10.2%)
Sep 2018
-
-$8.51 M(+31.8%)
-$29.78 M(+0.5%)
Jun 2018
-
-$6.46 M(+1.5%)
-$29.63 M(-6.0%)
Mar 2018
-
-$6.36 M(-24.6%)
-$31.52 M(+1.2%)
Dec 2017
-$31.15 M(+18.1%)
-$8.45 M(+1.0%)
-$31.15 M(+2.3%)
Sep 2017
-
-$8.36 M(+0.2%)
-$30.46 M(-15.7%)
Jun 2017
-
-$8.35 M(+39.1%)
-$36.14 M(+17.8%)
Mar 2017
-
-$6.00 M(-22.6%)
-$30.67 M(+16.2%)
Dec 2016
-$26.39 M(+285.5%)
-$7.75 M(-44.8%)
-$26.39 M(+28.6%)
Sep 2016
-
-$14.05 M(+388.3%)
-$20.52 M(+148.1%)
Jun 2016
-
-$2.88 M(+68.0%)
-$8.27 M(-67.2%)
Mar 2016
-
-$1.71 M(-9.0%)
-$25.20 M(-43.0%)
Dec 2015
-$6.84 M(-92.1%)
-$1.88 M(+4.6%)
-$44.19 M(-29.5%)
Sep 2015
-
-$1.80 M(-90.9%)
-$62.66 M(-22.5%)
Jun 2015
-
-$19.80 M(-4.4%)
-$80.83 M(-3.0%)
Mar 2015
-
-$20.71 M(+1.7%)
-$83.31 M(-3.3%)
Dec 2014
-$86.16 M
-$20.35 M(+1.9%)
-$86.16 M(-4.2%)
Sep 2014
-
-$19.97 M(-10.4%)
-$89.97 M(-2.8%)
Jun 2014
-
-$22.29 M(-5.4%)
-$92.52 M(-0.5%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$23.56 M(-2.5%)
-$93.02 M(+3.1%)
Dec 2013
-$90.19 M(+43.6%)
-$24.16 M(+7.3%)
-$90.19 M(+7.2%)
Sep 2013
-
-$22.52 M(-1.2%)
-$84.15 M(+9.8%)
Jun 2013
-
-$22.79 M(+9.9%)
-$76.63 M(+11.9%)
Mar 2013
-
-$20.73 M(+14.4%)
-$68.47 M(+9.0%)
Dec 2012
-$62.79 M(+32.5%)
-$18.12 M(+20.9%)
-$62.79 M(+13.3%)
Sep 2012
-
-$15.00 M(+2.6%)
-$55.41 M(+4.3%)
Jun 2012
-
-$14.62 M(-2.9%)
-$53.15 M(+4.2%)
Mar 2012
-
-$15.05 M(+40.1%)
-$51.03 M(+7.7%)
Dec 2011
-$47.38 M(+26.5%)
-$10.74 M(-15.6%)
-$47.38 M(+4.2%)
Sep 2011
-
-$12.73 M(+1.9%)
-$45.46 M(+5.8%)
Jun 2011
-
-$12.50 M(+9.7%)
-$42.99 M(+8.7%)
Mar 2011
-
-$11.40 M(+29.2%)
-$39.56 M(+5.6%)
Dec 2010
-$37.47 M(-147.4%)
-$8.82 M(-14.0%)
-$37.47 M(+5.0%)
Sep 2010
-
-$10.26 M(+13.1%)
-$35.68 M(-138.5%)
Jun 2010
-
-$9.07 M(-2.5%)
$92.70 M(-0.6%)
Mar 2010
-
-$9.31 M(+32.3%)
$93.28 M(+17.9%)
Dec 2009
$79.09 M(-185.4%)
-$7.04 M(-106.0%)
$79.09 M(+31.4%)
Sep 2009
-
$118.12 M(-1490.5%)
$60.17 M(-171.4%)
Jun 2009
-
-$8.49 M(-63.8%)
-$84.27 M(-14.4%)
Mar 2009
-
-$23.50 M(-9.5%)
-$98.47 M(+6.3%)
Dec 2008
-$92.62 M(+45.9%)
-$25.95 M(-1.4%)
-$92.62 M(+12.7%)
Sep 2008
-
-$26.32 M(+16.0%)
-$82.19 M(+16.2%)
Jun 2008
-
-$22.69 M(+28.6%)
-$70.74 M(+9.2%)
Mar 2008
-
-$17.65 M(+13.7%)
-$64.79 M(+2.0%)
Dec 2007
-$63.49 M(+10.9%)
-$15.52 M(+4.4%)
-$63.49 M(+5.0%)
Sep 2007
-
-$14.88 M(-11.1%)
-$60.46 M(+1.6%)
Jun 2007
-
-$16.74 M(+2.4%)
-$59.51 M(+3.1%)
Mar 2007
-
-$16.36 M(+31.0%)
-$57.70 M(+2.5%)
Dec 2006
-$57.27 M(-16.8%)
-$12.49 M(-10.3%)
-$56.27 M(-5.1%)
Sep 2006
-
-$13.93 M(-6.7%)
-$59.27 M(-17.7%)
Jun 2006
-
-$14.93 M(0.0%)
-$72.03 M(-14.0%)
Mar 2006
-
-$14.93 M(-3.6%)
-$83.79 M(-3.4%)
Dec 2005
-$68.86 M(+49.9%)
-$15.49 M(-41.9%)
-$86.72 M(+21.7%)
Sep 2005
-
-$26.69 M(0.0%)
-$71.23 M(+59.9%)
Jun 2005
-
-$26.69 M(+49.4%)
-$44.54 M(+149.4%)
Mar 2005
-
-$17.86 M(+103.9%)
-$17.86 M(+103.9%)
Dec 2004
-$45.93 M(+64.8%)
-
-
Mar 2004
-
-$8.76 M
-$8.76 M
Dec 2003
-$27.88 M(-22.9%)
-
-
Dec 2002
-$36.15 M(+9389.2%)
-
-
Dec 2001
-$381.00 K
-
-

FAQ

  • What is Madrigal Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals annual net income year-on-year change?
  • What is Madrigal Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly net income year-on-year change?
  • What is Madrigal Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals TTM net income year-on-year change?

What is Madrigal Pharmaceuticals annual net profit?

The current annual net income of MDGL is -$373.63 M

What is the all time high annual net income for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual net profit is $79.09 M

What is Madrigal Pharmaceuticals annual net income year-on-year change?

Over the past year, MDGL annual net profit has changed by -$78.28 M (-26.50%)

What is Madrigal Pharmaceuticals quarterly net profit?

The current quarterly net income of MDGL is -$106.96 M

What is the all time high quarterly net income for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly net profit is $118.12 M

What is Madrigal Pharmaceuticals quarterly net income year-on-year change?

Over the past year, MDGL quarterly net profit has changed by +$45.01 M (+29.62%)

What is Madrigal Pharmaceuticals TTM net profit?

The current TTM net income of MDGL is -$518.67 M

What is the all time high TTM net income for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high TTM net profit is $93.28 M

What is Madrigal Pharmaceuticals TTM net income year-on-year change?

Over the past year, MDGL TTM net profit has changed by -$8.22 M (-1.61%)